Differences of two cryoballoon generations: insights from the prospective multicentre, multinational FREEZE Cohort Substudy
Open Access
- 3 July 2014
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in EP Europace
- Vol. 16 (10), 1434-1442
- https://doi.org/10.1093/europace/euu162
Abstract
Cryoballoon (CB) ablation with the second-generation cryoballoon (CBG2) seems to be more effective than its predecessor [first-generation cryoballoon (CBG1)], but phrenic nerve palsies were observed more frequently. The aim of this study was to compare the safety and efficacy of CBG1 and CBG2 in a substudy of the prospective multicentre, multinational FREEZE Cohort Study. Periprocedural data were analysed, and a total of 532 patients with paroxysmal atrial fibrillation (AF) were examined (n = 224 for CBG1 and n = 308 for CBG2). Procedure time decreased significantly from 149 to 130 min when comparing CBG1 with CBG2 (P < 0.0001), and pulmonary vein isolation (PVI) was achieved in 97.8 and 97.6% of PVs with CBG1 and CBG2 (P = 0.77), respectively. The need for dual-balloon usage within a procedure dropped (20.1 vs. 9.0%, P < 0.001), and the fluoroscopy time was reduced when operating the CBG2. Atrial fibrillation recurrence rates until discharge were similar (5.0 vs. 5.8%, P = 0.69). Comparable low rates of major complications were observed with both CBs, and there was a non-significant trend for more phrenic nerve palsies. Second-generation cryoballoon demonstrated a high rate of acute PVI in a significant faster procedure, which also utilized less radiation exposure and less dual-balloon usage during an average procedure. The safety profile remains favourable with a non-significant trend for more phrenic nerve palsies. If the enhancements lead to a higher clinical benefit has to be determined. The 1-year outcome data from the ongoing FREEZE Cohort Study comparing radiofrequency and CB ablation will shed some light on that issue. NCT01360008.Keywords
This publication has 27 references indexed in Scilit:
- Worldwide Epidemiology of Atrial FibrillationCell Metabolism, 2014
- Cryoballoon Ablation of Pulmonary Veins for Paroxysmal Atrial FibrillationJournal of the American College of Cardiology, 2013
- Long-Term Outcomes After Cryoballoon Pulmonary Vein IsolationJournal of the American College of Cardiology, 2013
- Incidence and prevalence of atrial fibrillation: an analysis based on 8.3 million patientsEP Europace, 2012
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillationEP Europace, 2012
- The Biophysics and Biomechanics of Cryoballoon AblationPacing and Clinical Electrophysiology, 2012
- 2012 HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial DesignA report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm SocietyEP Europace, 2012
- Efficacy and safety of cryoballoon ablation for atrial fibrillation: A systematic review of published studiesHeart Rhythm, 2011
- Pulmonary Vein Isolation for the Maintenance of Sinus Rhythm in Patients With Atrial FibrillationCirculation: Arrhythmia and Electrophysiology, 2009
- Secular Trends in Incidence of Atrial Fibrillation in Olmsted County, Minnesota, 1980 to 2000, and Implications on the Projections for Future PrevalenceCell Metabolism, 2006